Skip to main content

Table 2 Demographics

From: The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial

Parameter   BEXIDEM
N = 75
BCG
N = 78
Age    
  Mean 63 62.8
  Median 63 64.5
  Range 43-83 27-83
Sex    
  Male 62 (83%) 64(82%)
  Female 13 (17%) 14 (18%)
Ethnic Group    
  Caucasian 75 (100%) 77 (99%)
  Mediterranean 0 (0%) 1 (1%)